Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Betamethasone sodium phosphate (Ear/Eye/Nasal)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Betamethasone 0.1% ear/eye/nose drops
1104010D0AAAGAG
|
Betamethasone sodium phosphate (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | 41,459 |
|
Betamethasone 0.1% eye ointment
1104010D0AAABAB
|
Betamethasone sodium phosphate (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | No data available |
|
Neomycin 0.5% / Betamethasone 0.1% eye ointment
1104010D0AAADAD
|
Betamethasone sodium phosphate (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.